BOSTON — Neurable announced it has raised $35 million in a Series A financing round to accelerate the commercialization of its noninvasive brain-computer interface technology designed for everyday consumer use.
The funding brings Neurable’s total capital raised to $65 million and will support the expansion of Neurable AI, the company’s patented compact brain-signal processing technology that integrates brain-computer interface capabilities into consumer devices. The round was led by Spectrum Moonshot Fund.
Neurable said the investment will help advance its goal of bringing neurotechnology out of research settings and into daily life, positioning brain insights alongside commonly used health metrics such as heart rate and sleep tracking. The company recently introduced the MW75 Neuro LT and an updated mobile app that delivers real-time insights into mental fatigue, cognitive recovery, and focus states.
According to Neurable, these capabilities are powered by Neurable AI and have been validated through multiple independent evaluations and peer-reviewed studies, demonstrating the system’s ability to detect focus, distraction, and changes in cognitive state with high accuracy.
“Our mission is to make understanding your brain as natural and intuitive as checking your steps,” said Dr. Ramses Alcaide, CEO and co-founder of Neurable. “With the MW75 Neuro LT and the redesigned Neurable app, people can finally see how their mind performs throughout the day. This funding allows us to scale Neurable AI into new devices and new industries, making cognitive health an accessible, daily utility for everyone.”
Investors cited growing demand for brain-centered wellness and performance tools. Mauro Guebeli, investment manager at Spectrum Value Management, said Neurable has successfully brought high-quality brain-computer interface technology into a consumer-ready product supported by advanced signal-processing algorithms.
Existing investors also participated in the round. “We view Neurable as a leader in translating deep scientific breakthroughs into an effective, accessible, and desirable consumer product that can harness the power of the human brain for more conscious and healthier lives,” said Marius Swart, managing partner at Pace Ventures.
Neurable said the Series A funding will support expansion across cognitive health and human performance markets, with a particular focus on gaming and e-sports, where small improvements in concentration, reaction time, and cognitive endurance can influence competitive performance.
“Gaming is one of the most immediate and intuitive applications of Neurable AI,” said Adam Molnar, co-founder and vice president of strategic partnerships at Neurable. “Players are constantly pushing their cognitive limits. By integrating brain insights directly into gaming workflows and devices, we’re opening a new frontier in player performance and game design.”
Beyond gaming, Neurable is continuing to grow its presence in research and emerging BCI-enabled product categories. The company recently partnered with iMotions to integrate Neurable headsets into its human behavior research platform, enabling large-scale neural data collection. It has also collaborated with MeSpace to study how adaptive workstations influence cognitive performance.
As the global brain-computer interface market is projected to exceed $52 billion by 2034, Neurable said it aims to lead the shift toward making brain data a foundational element in how people work, play, and manage their well-being.
